{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:34:01Z","timestamp":1792528441970,"version":"4.5.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Melanoma is a highly aggressive skin malignancy characterized by early metastasis, marked therapeutic resistance, and poor clinical outcomes in advanced disease. Increasing evidence indicates that immune dysregulation within the tumor microenvironment (TME) is a central determinant of melanoma progression, metastatic dissemination, and treatment failure. The melanoma immune microenvironment is shaped by complex interactions among tumor-associated macrophages, tumor-infiltrating lymphocytes, regulatory T cells, myeloid-derived suppressor cells, stromal cells, endothelial cells, and extracellular matrix components, together with hypoxia and acidosis, all of which cooperatively drive immune evasion, chronic inflammation, angiogenesis, and resistance to therapy. Mechanistically, cancer-associated fibroblasts promote immune tolerance by secreting CXCL12 and CCL17, thereby recruiting regulatory T cells and reinforcing a suppressive stromal niche; melanoma-derived factors and metabolic perturbations reprogram tumor-associated macrophages toward a pro-tumoral phenotype through lipid metabolic remodeling, endoplasmic reticulum stress, and immunosuppressive mediator production; and hypoxic stress amplifies CD39\/CD73-dependent adenosine generation, which suppresses dendritic cell maturation and cytotoxic T-cell activity while facilitating immune escape. These immunosuppressive networks not only impair effective antitumor immune surveillance but also limit the long-term efficacy of immune checkpoint blockade and other systemic treatments. This review summarizes the immunopathological mechanisms underlying melanoma progression within the immune microenvironment and highlights emerging therapeutic strategies targeting immune and stromal crosstalk, providing a valuable theoretical basis for understanding melanoma immune escape and an important reference for the development of more effective and durable immunotherapeutic interventions.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1847963","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:29:52Z","timestamp":1778477392000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The immune landscape of melanoma microenvironmental crosstalk"],"prefix":"10.3389","volume":"17","author":[{"given":"Qianqian","family":"Yang","sequence":"first","affiliation":[{"name":"Clinical Medical College, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjing","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Xu","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Medical Aesthetics, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Aesthetics, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winjin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Acupuncture and Moxibustion, Zhaoyang District Hospital of Traditional Chinese Medicine","place":["Zhaotong, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medical Aesthetics, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5817","article-title":"Neuroendocrine factors: the missing link in non-melanoma melanoma (review)","volume":"38","author":"Shirley","year":"2017","journal-title":"Oncol Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2024.54","article-title":"Behavioral counseling to prevent melanoma: US preventive services task force recommendation statement","volume":"319","author":"Jalil","year":"2018","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.01.011","article-title":"Melanoma models for the next generation of therapies","volume":"39","author":"Patton","year":"2021","journal-title":"Cancer Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4476","article-title":"Hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas","volume":"24","author":"Ma","year":"2018","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00813-8","article-title":"Unexpected guests in the tumor microenvironment: microbiome in cancer","volume":"12","author":"Wong-Rolle","year":"2021","journal-title":"Protein Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-20-2793","article-title":"Cancer-associated neurogenesis and nerve-cancer cross-talk","volume":"81","author":"Silverman","year":"2021","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101592","article-title":"Impact of collagen triple helix structure on melanoma cell invadopodia formation and matrix degradation upon BRAF inhibitor treatment","volume":"11","author":"Shin","year":"2022","journal-title":"Adv Healthc Mater"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12040534","article-title":"Association of elevated expression levels of COL4A1 in stromal cells with an immunosuppressive tumor microenvironment in low-grade glioma, pancreatic adenocarcinoma, skin cutaneous melanoma, and stomach adenocarcinoma","volume":"12","author":"Shin","year":"2022","journal-title":"J Pers Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.864302","article-title":"The role of extracellular matrix remodeling in skin tumor progression and therapeutic resistance","volume":"9","author":"Fromme","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-02490-3","article-title":"How cancer invasion takes shape","volume":"585","author":"Punovuori","year":"2020","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2018.03.006","article-title":"Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and Malignant melanoma","volume":"79","author":"Sasaki","year":"2018","journal-title":"Hum Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.jid.2020.03.950","article-title":"TRAF6 activates fibroblasts to cancer-associated fibroblasts through FGF19 in tumor microenvironment to benefit the Malignant phenotype of melanoma cells","volume":"140","author":"Guo","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147255","article-title":"Profiling cancer-associated fibroblasts in melanoma","volume":"22","author":"Papaccio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-016-1433-8","article-title":"Simultaneous blocking of IL-6 and IL-8 is sufficient to fully inhibit CAF-induced human melanoma cell invasiveness","volume":"146","author":"Jobe","year":"2016","journal-title":"Histochem Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13046-018-0911-3","article-title":"Melanoma cell secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1 \/JAK2 \/ STAT3 signaling pathway","volume":"37","author":"Zhou","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1186\/s12885-017-3663-0","article-title":"Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin","volume":"17","author":"Papaccio","year":"2017","journal-title":"BMC Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14150","article-title":"Exploring vitamin D signalling within melanoma","volume":"92","author":"Vishlaghi","year":"2020","journal-title":"Clin Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3892\/mmr.2021.12408","article-title":"Overview of the molecular mechanisms contributing to the formation of cancer-associated adipocytes (review)","volume":"24","author":"Tang","year":"2021","journal-title":"Mol Med Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m114.593210","article-title":"Subcutaneous adipocytes promote melanoma cell growth by activating the Akt signaling pathway: role of palmitic acid","volume":"289","author":"Kwan","year":"2014","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-16-0651","article-title":"Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer","volume":"76","author":"Lazar","year":"2016","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.927118","article-title":"Targeting of the lipid metabolism impairs resistance to BRAF kinase inhibitor in melanoma","volume":"10","author":"Vergani","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28456","article-title":"Conditioned media from adipocytes promote proliferation, migration, and invasion in melanoma and colorectal cancer cells","volume":"234","author":"Ko","year":"2019","journal-title":"J Cell Physiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cca.2021.01.013","article-title":"Leptin in skin disease modulation","volume":"516","author":"Su","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2174\/0929867321666131129114742","article-title":"Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy","volume":"21","author":"Chi","year":"2014","journal-title":"Curr Med Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153111","article-title":"Clinical-pathological significance of leptin receptor (LEPR) expression in squamous cell carcinoma of the skin","volume":"216","author":"Ellerhorst","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092281","article-title":"Melanoma progression under obesity: focus on adipokines","volume":"13","author":"Olsza\u0144ska","year":"2021","journal-title":"Cancers"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-020-00563-6","article-title":"In silico analyses of the tumor microenvironment highlight tumoral inflammation, a Th2 cytokine shift and a mesenchymal stem cell-like phenotype in advanced in basal cell carcinomas","volume":"14","author":"Lefran\u00e7ois","year":"2020","journal-title":"J Cell Commun Signal"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2017.218","article-title":"Role of adipose tissue in melanoma cancer microenvironment and progression","volume":"42","author":"oico","year":"2018","journal-title":"Int J Obes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jid.2020.08.012","article-title":"Noncanonical EphA2 signaling is a driver of tumor-endothelial cell interactions and metastatic dissemination in BRAF inhibitor-resistant melanoma","volume":"141","author":"Zhang","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2021.04.005","article-title":"ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3","volume":"510","author":"Coppo","year":"2021","journal-title":"Cancer Lett"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1738-z","article-title":"Increased expression of uPA, uPAR, and PAI-1 in psoriatic skin and in basal cell carcinomas","volume":"309","author":"Serrat\u00ec","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03707-4","article-title":"uPAR-expressing melanoma exosomes promote angiogenesis by VE-cadherin, EGFR and uPAR overexpression and rise of ERK1\/2 signaling in endothelial cells","volume":"78","author":"Biagioni","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-20-0784","article-title":"MHC class II antigen presentation by lymphatic endothelial cells in tumors promotes intratumoral regulatory T cell suppressive functions","volume":"9","author":"Wu","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1593\/neo.09266","article-title":"Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3\/Akt\/ERK signaling","volume":"11","author":"Serrat\u00ec","year":"2009","journal-title":"Neoplasia"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093555","article-title":"Depletion of cutaneous macrophages and dendritic cells promotes growth of basal cell carcinoma in mice","volume":"9","author":"Habib","year":"2014","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020464","article-title":"Melanoma-derived exosomal miR-125b-5p educates tumor associated macrophages (TAMs) by targeting lysosomal acid lipase A (LIPA)","volume":"12","author":"Gerloff","year":"2020","journal-title":"Cancers"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01047-4","article-title":"Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity","volume":"22","author":"Di Conza","year":"2021","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9735","article-title":"Inflammation: a key process in skin tumorigenesis","volume":"17","author":"Sun","year":"2019","journal-title":"Oncol Lett"},{"key":"B41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41419-019-2010-6","article-title":"ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12","volume":"10","author":"Kloss","year":"2019","journal-title":"Cell Death Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2217\/mmt.15.37","article-title":"The role of tumor microenvironment in melanoma therapy resistance","volume":"3","author":"Somasundaram","year":"2016","journal-title":"Melanoma Manag"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/srep19012","article-title":"Large molecular systems landscape uncovers T cell trapping in human melanoma","volume":"6","author":"Hillert","year":"2016","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02105","article-title":"Tumor-infiltrating lymphocytes and their prognostic value in cutaneous melanoma","volume":"11","author":"Maibach","year":"2020","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183415","article-title":"Expression of IL-23\/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments","volume":"12","author":"Moldoveanu","year":"2017","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167901","article-title":"Sparsity of dendritic cells and cytotoxic T cells in tumor microenvironment may lead to recurrence in basal cell carcinoma","volume":"59","author":"Marrapodi","year":"2020","journal-title":"Int J Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/cup.13123","article-title":"Evaluation of T-lymphocyte subpopulations in actinic keratosis, in situ and invasive squamous cell carcinoma of the skin","volume":"45","author":"Bida","year":"2018","journal-title":"J Cutan Pathol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41419-020-02758-6","article-title":"Inactivating p53 is essential for nerve growth factor receptor to promote melanoma-initiating cell-stemmed tumorigenesis","volume":"11","author":"Jiang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-3872","article-title":"Melanoma-induced reprogramming of schwann cell signaling aids tumor growth","volume":"79","author":"Shurin","year":"2019","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.818868","article-title":"Identification of lactate-related gene signature for prediction of progression and immunotherapeutic response in skin cutaneous melanoma","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-020-01959-y","article-title":"The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells","volume":"98","author":"Andreucci","year":"2020","journal-title":"J Mol Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004043","article-title":"Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents","volume":"10","author":"Turiello","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104182","article-title":"Targeting the negative feedback of adenosine-A2AR metabolic pathway by a tailored nanoinhibitor for photothermal immunotherapy","volume":"9","author":"Liu","year":"2022","journal-title":"Adv Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33786","article-title":"Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors","volume":"149","author":"Mori","year":"2021","journal-title":"Int J Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.659332","article-title":"Tissue expression of carbonic anhydrase IX correlates to more aggressive phenotype of basal cell carcinoma","volume":"24","author":"Venturella","year":""},{"key":"B56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2022.2032646","article-title":"Advances in the drug management of basal cell carcinoma","volume":"23","author":"Lauss","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-20-0591","article-title":"CSF1 \/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Turner","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41467-022-29388-0","article-title":"Depletion of tumor associated macrophages enhances local and systemic platelet mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nature20554","article-title":"Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells","volume":"539","author":"De Henau","year":"2016","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.739161","article-title":"Tumor-associated extracellular matrix: how to be a potential aide to anti-tumor immunotherapy","volume":"9","author":"He","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7818","article-title":"Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+ T cells within tumors","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26124","article-title":"Complex formation between platelet-derived growth factor receptor \u03b2 and transforming growth factor \u03b2 receptor regulates the differentiation of mesenchymal stem cells into cancer-associated fibroblasts","volume":"9","author":"Aoto","year":"2018","journal-title":"Oncotarget"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.7150\/thno.37851","article-title":"Specific targeting of PDGFR\u03b2 in the stroma inhibits growth and angiogenesis in tumors with high PDGF-BB expression","volume":"10","author":"Tsioumpekou","year":"2020","journal-title":"Theranostics"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-06-1586","article-title":"A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors","volume":"13","author":"Chiappori","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13046-020-01820-7","article-title":"Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy","volume":"40","author":"Wang","year":"2021","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1847963\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:29:53Z","timestamp":1778477393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1847963\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2026.1847963"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1847963","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"article-number":"1847963"}}